BridgeMD
Compares treatment options for Transfemoral Amputees
Official title Impairment Oriented Versus Task Oriented Gait Training In Transfemoral Amputee Rehabilitation.
ClinicalTrials.gov ID: NCT07578051
What this study is testing
- What it's testing
- This study examines the comparison between Impairment Oriented versus Task Oriented Gait Training in Transfemoral Amputee Rehabilitation. A randomized controlled trial conducted with 40 participants divided into two groups .Both groups receive pre-gait training and corrective walking exercises for 10 days .
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40
You may be able to join if
- Age 18-40 years
- Unilateral transfemoral amputees
- Cleared by physicians for participation in physical therapy
- Willing
You likely can't join if
- Residual limb complication that interfere with mobility
- History of neurological disorders
- Any joint complication in intact limb
- Currently enrolled in another research study
- Mild to severe cognitive impairment (MoCA) i.e , score less than 25 , Uncontrolled diabetes
The study team makes the final eligibility decision.
Where it's taking place
- Islamabad, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Islamabad, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.